Loading...
StocksRunner logo
 
 
Amgen
221.26
+0.02%
 
AMGN Amgen
Last Price
Change
221.26
 
+0.02%
 
 
 

 
Sentiment
 
  Login to display
 
 

240.34

234.9

252.4

245.37

 
 
1m
3m
6m
1y
 

Summary

  Login to display Amgen (AMGN) recommendation from the last 90 days from financial news and social media.
 

Strengths

Rewards

 Outperform the market

 

Risk Analysis

Risk Analysis

 Enter oversold territory

 
 

Risk Level

 
StocksRunner
 

Amgen (AMGN) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

3.11
 

StocksRunner

 Above analyst estimates

StocksRunner

 Earnings decline YoY

StocksRunner

 Reported a strong earnings

StocksRunner

 Revenue declined YoY

 
 

Rating

×
 

Rating

1.67
 
 

Momentum

×
 

Momentum

2.75
 

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.55
 
 

Future

×
 

Future

3.80
 

StocksRunner

 Outperform the market

 
 

Analysts Opinion

Analysts opinion is negative and has getting worse from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
53%
0%
25%
80%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
53%
30%
Positive
Negative
34 out of 64
events present
19 out of 64
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Options Activity
This Week
214.26
-2.90%
 
Options Activity
2 Weeks Ago
221.07
-1.50%
 
Options Activity
3 Weeks Ago
224.68
-0.48%
 
Dividend Declares
3 Weeks Ago
233.53
+0.25%
 
Strong Earnings
2 Month Ago
239.64
-0.29%
 
Similar Peers
Score
Closing
Price
%
Change

HZNP

Horizon Therapeutics Publ

2.70

99.30

-0.51%

 

AZN

Astrazeneca

4.13

73.42

+0.02%

 
 
Top Headlines

heres how much $1000 invested in amgen 15 years ago would be worth today. amgen (nasdaq:) has outperformed the market over the past 15 years by 3.48% on an annualized basis producing an average annual return of 11.44%. currently amgen has a market capital

Mon Jun 5, 2023

Activity

amgen sees potential for horizon to close by mid-december under court schedule.

Mon Jun 5, 2023

Potential

amgen (amgn) shares cross 4% yield mark. looking at the universe of stocks we cover at dividend channel in trading on thursday shares of amgen inc (symbol: amgn) were yielding above the 4% mark based on its quarterly dividend (annualized to

Thu Jun 1, 2023

Activity

notable thursday option activity: amgn abbv rcl. looking at options trading activity among components of the s&.p 500 index there is noteworthy activity today in amgen inc (symbol: amgn) where a total volume of 19544 contracts has been tr

Thu Jun 1, 2023

Momentum

amgen: now at a record high yield.

Tue May 30, 2023

Momentum

noteworthy wednesday option activity: amgn gpre reta. looking at options trading activity among components of the russell 3000 index there is noteworthy activity today in amgen inc (symbol: amgn) where a total volume of 14209 contracts has b

Wed May 24, 2023

Momentum

us judge hearing fight over amgen deal for horizon eyes september trial. the judge who will decide if amgen can go forward with its $27.8 billion purchase of horizon therapeutics on tuesday said he was considering an evidentiary hearing on the m

Tue May 23, 2023

Activity

dow movers: wba amgn. in early trading on monday shares of amgen topped the list of the days best performing dow jones industrial average components trading up 1.2%. year to date amgen has lost about 13.9% of its value.

Mon May 22, 2023

Momentum

ideaya announces fda nod to run amgen-sponsored tumor study.

Mon May 22, 2023

Activity

oppenheimer reiterates amgen (amgn) outperform recommendation. fintel reports that on may 18 2023 oppenheimer reiterated coverage of amgen (nasdaq:amgn) with a outperform recommendation. analyst price forecast suggests 16.17% upside

Thu May 18, 2023

Potential

amgen agrees not to seek quick close to horizon acquisition. amgen inc has agreed not to quickly close on its $27.8 billion acquisition of horizon therapeutics after the United States federal trade commission (ftc) filed suit to block the deal.

Thu May 18, 2023

Activity

amgen agrees not to close horizon deal before sept. 15 in court agreement with ftc.

Thu May 18, 2023

Activity

United States court issues temporary restraining order on $27.8 bln amgen-horizon deal. a United States district court has issued a temporary restraining order on amgen incs $27.8 billion acquisition of horizon therapeutics following a submissio

Thu May 18, 2023

Activity

ftc effort to stop amgens horizon takeover faces uphill fight.

Thu May 18, 2023

Activity

unusual put option trade in amgen (amgn) worth $6563.75k. on may 17 2023 at 11:26:46 et an unusually large $6563.75k block of put contracts in amgen (amgn) was sold with a strike price of $245.00 / share expiring in 65 day(s) (on july 21 2023)

Wed May 17, 2023

Momentum

unusual put option trade in amgen (amgn) worth $9481.50k. on may 17 2023 at 14:36:36 et an unusually large $9481.50k block of put contracts in amgen (amgn) was bought with a strike price of $250.00 / share expiring in 30 day(s) (on june 16 202

Wed May 17, 2023

Momentum

ftc challenges amgens (amgn) $28b acquisition of horizon. on tuesday the federal trade commission (&ldquo.ftc&rdquo.) filed a lawsuit in federal court to halt biotech giant amgens amgn $28 billion acquisition of horizon therapeutics hz

Wed May 17, 2023

Activity

noteworthy wednesday option activity: amgn lkq lyv. looking at options trading activity among components of the s&.p 500 index there is noteworthy activity today in amgen inc (symbol: amgn) where a total volume of 32927 contracts has been

Wed May 17, 2023

Momentum

amgen deal for horizon likely to go through despite ftc objection: guggenheim.

Wed May 17, 2023

Activity

amgen becomes oversold. the dividendrank formula at dividend channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &m

Wed May 17, 2023

Earnings
Momentum

ftc may reportedly block amgens (amgn) $28b horizon buyout. shares of horizon therapeutics hznp were down 15% in after-market trading on may 15 after multiple third-party articles stated that the federal trade commission (&ldquo.ftc&rd

Tue May 16, 2023

Activity

United States sues to block amgens $27.8 billion takeover of horizon therapeutics. the federal trade commission said the deal would enable amgen to entrench the monopoly positions of two horizon drugs that lack competition.

Tue May 16, 2023

Activity

ftc moves to block amgens $27.8 billion deal for horizon therapeutics. the ftc filed a lawsuit in federal court seeking an injunction that would prevent the deal from closing.

Tue May 16, 2023

Activity

horizon therapeutics falls on ftcs reported move to challenge amgens $28 bln deal. (rttnews) - horizon therapeutics public ltd co. (hznp) shares are sliding more than 17 percent on tuesday morning trade after the United States federal trade comm

Tue May 16, 2023

Activity

ftc poised to block amgens $27.8 billion deal for horizon therapeutics. the ftc is preparing to seek an injunction in federal court that would prevent the deal from closing.

Tue May 16, 2023

Activity

amgen-horizon therapeutics deal regulatory overhang: ftc plans lawsuit to block $28b takeover. the federal trade commission is expected to file a lawsuit in a bid to block) $28 billion takeover of). in december amgen agreed to buy horizon therapeutics at

Tue May 16, 2023

Activity

ftc to block amgens deal to buy horizon - bloomberg news. the us federal trade commission (ftc) is expected to file a lawsuit on tuesday to block amgen incs $27.8 billion deal to buy horizon therapeutics plc citing risks to competition in drug d

Tue May 16, 2023

Activity

ftc to block amgens deal to acquire horizon - source. the us federal trade commission (ftc) is expected to file a lawsuit as early as tuesday to block amgen incs deal to buy horizon therapeutics plc a person familiar with the matter told reuters

Tue May 16, 2023

Activity

ex-dividend reminder: amgen select medical holdings and laboratory corporation of america holdings. looking at the universe of stocks we cover at dividend channel on 5/17/23 amgen inc (symbol: amgn) select medical holdings corp (symbol: sem)

Mon May 15, 2023

Activity

tscan jumps 102% after deal with amgen for crohns disease.

Tue May 9, 2023

Activity
Momentum

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily AMGN alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

AMGN Amgen

Last Price
221.26
Change
+0.02%
 

Summary

  Login to display Amgen (AMGN) recommendation from the last 90 days from financial news and social media.

 
 
240.34
234.9
252.4
245.37
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Strengths

Rewards

 Outperform the market

Risk Analysis

Risk Analysis

 Enter oversold territory

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
0%
25%
80%
On Track
On Track
On Track
 
53%
30%
Positive
Negative
34 out of 64
events present
19 out of 64
events present
 

Street Opinion

Street view is bullish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

3.11
 

StocksRunner

 Above analyst estimates

StocksRunner

 Earnings decline YoY

StocksRunner

 Reported a strong earnings

StocksRunner

 Revenue declined YoY

 
 

Rating

×
 

Rating

1.67
 
 

Momentum

×
 

Momentum

2.75
 

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.55
 
 

Future

×
 

Future

3.80
 

StocksRunner

 Outperform the market

 
 

Analysts Opinion

Analysts opinion is negative and has getting worse from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Amgen (AMGN) has Low Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Options Activity
This Week
214.26
-2.90%
 
Options Activity
2 Weeks Ago
221.07
-1.50%
 
Options Activity
3 Weeks Ago
224.68
-0.48%
 
Dividend Declares
3 Weeks Ago
233.53
+0.25%
 
Strong Earnings
2 Month Ago
239.64
-0.29%
 
 
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily AMGN Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines